Bank of Montreal
GNCA

Bank of Montreal’s Genocea Biosciences, Inc. GNCA Stock Holding History

Bank of Montreal’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,250
Closed -$41K – 4280
2016
Q2 		$41K Buy
1,250
+1,247
+41,567% +$45.7K ﹤0.01% 3131
2016
Q1 		$0 Hold
3
– – ﹤0.01% 4506
2015
Q4 		$0 Hold
3
– – ﹤0.01% 4521
2015
Q3 		$0 Hold
3
– – ﹤0.01% 4248
2015
Q2 		$0 Hold
3
– – ﹤0.01% 4208
2015
Q1 		$0 Hold
3
– – ﹤0.01% 4297
2014
Q4 		$0 Buy
+3
New +$205 ﹤0.01% 4252
2014
Q3 		– Sell
-14
Closed -$1.53K – 4617
2014
Q2 		$2K Buy
+14
New +$2.12K ﹤0.01% 4540

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Bank of Montreal's GNCA Position: Q3 2016 in Review

Bank of Montreal sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2016, closing a stake of 1,250 shares — an estimated $41K sold.

Bank of Montreal first reported a position in GNCA in Q2 2014 and held it in 8 quarters. The position peaked at $41K in Q2 2016. 48 funds tracked by Wall St. Rank hold GNCA as of Q3 2016.

  • Bank of Montreal reported no remaining Genocea Biosciences, Inc. position as of Q3 2016 after selling out during the quarter.
  • Bank of Montreal sold 1,250 Genocea Biosciences, Inc. shares in Q3 2016, an estimated $41K.
  • Bank of Montreal first reported a position in Genocea Biosciences, Inc. in Q2 2014 and held it in 8 quarters.
  • Bank of Montreal's Genocea Biosciences, Inc. position peaked at $41K in Q2 2016.
  • 48 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2016.

Based on Bank of Montreal's 13F filing for Q3 2016, filed 19 Oct 2016.